132 related articles for article (PubMed ID: 8434001)
1. Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus.
Bell KD; Ramilo O; Vitetta ES
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1411-5. PubMed ID: 8434001
[TBL] [Abstract][Full Text] [Related]
2. Role of CD25+ and CD25-T cells in acute HIV infection in vitro.
Ramilo O; Bell KD; Uhr JW; Vitetta ES
J Immunol; 1993 Jun; 150(11):5202-8. PubMed ID: 8496611
[TBL] [Abstract][Full Text] [Related]
3. The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus.
Borvak J; Chou CS; Van Dyke G; Rosenwirth B; Vitetta ES; Ramilo O
J Infect Dis; 1996 Oct; 174(4):850-3. PubMed ID: 8843228
[TBL] [Abstract][Full Text] [Related]
4. The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells.
Mlynar E; Bevec D; Billich A; Rosenwirth B; Steinkasserer A
J Gen Virol; 1997 Apr; 78 ( Pt 4)():825-35. PubMed ID: 9129655
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Martin PJ; Pei J; Gooley T; Anasetti C; Appelbaum FR; Deeg J; Hansen JA; Nash RA; Petersdorf EW; Storb R; Ghetie V; Schindler J; Vitetta ES
Biol Blood Marrow Transplant; 2004 Aug; 10(8):552-60. PubMed ID: 15282533
[TBL] [Abstract][Full Text] [Related]
6. An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro.
McCoig C; Van Dyke G; Chou CS; Picker LJ; Ramilo O; Vitetta ES
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11482-5. PubMed ID: 10500202
[TBL] [Abstract][Full Text] [Related]
7. A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro.
Vaclavkova P; Cao Y; Wu LK; Michalek J; Vitetta ES
Bone Marrow Transplant; 2006 Mar; 37(6):559-67. PubMed ID: 16444279
[TBL] [Abstract][Full Text] [Related]
8. Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin.
Cavazzana-Calvo M; Fromont C; Le Deist F; Lusardi M; Coulombel L; Derocq JM; Gerota I; Griscelli C; Fischer A
Transplantation; 1990 Jul; 50(1):1-7. PubMed ID: 2142343
[TBL] [Abstract][Full Text] [Related]
9. Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function.
Rasmussen RA; Counts SL; Lambert JM; Collinson AR
Cancer Immunol Immunother; 1992; 35(5):355-63. PubMed ID: 1394340
[TBL] [Abstract][Full Text] [Related]
10. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
Hansen BD; Nara PL; Maheshwari RK; Sidhu GS; Bernbaum JG; Hoekzema D; Meltzer MS; Gendelman HE
J Virol; 1992 Dec; 66(12):7543-8. PubMed ID: 1279206
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous activation of human immunodeficiency virus type 1 in an immunotoxin-resistant variant T cell line.
Fang H; Pincus S
AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1345-9. PubMed ID: 10515150
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxin depletion of T cells and its effect on hematopoietic progenitor cells in human cord blood.
Xu M; Lu S; Shen B; Li Y
Chin Med J (Engl); 2001 Apr; 114(4):355-9. PubMed ID: 11780453
[TBL] [Abstract][Full Text] [Related]
13. Highly purified CD25- resting T cells cannot be infected de novo with HIV-1.
Chou CS; Ramilo O; Vitetta ES
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1361-5. PubMed ID: 9037058
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.
Till MA; Zolla-Pazner S; Gorny MK; Patton JS; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1987-91. PubMed ID: 2538826
[TBL] [Abstract][Full Text] [Related]
15. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
Shen GL; Li JL; Vitetta ES
J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
[TBL] [Abstract][Full Text] [Related]
16. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin.
Michálek J; Collins RH; Vitetta ES
Neoplasma; 2003; 50(4):296-9. PubMed ID: 12937844
[TBL] [Abstract][Full Text] [Related]
17. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.
Holm GH; Gabuzda D
J Virol; 2005 May; 79(10):6299-311. PubMed ID: 15858014
[TBL] [Abstract][Full Text] [Related]
18. Effects of cytokines on HIV-1 production by thymocytes.
Uittenbogaart CH; Anisman DJ; Zack JA; Economides A; Schmid I; Hays EF
Thymus; 1994-1995; 23(3-4):155-75. PubMed ID: 8525503
[TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.
Pincus SH; Cole RL; Hersh EM; Lake D; Masuho Y; Durda PJ; McClure J
J Immunol; 1991 Jun; 146(12):4315-24. PubMed ID: 1710247
[TBL] [Abstract][Full Text] [Related]
20. L-2-oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chain.
Lederman MM; Georges D; Dando S; Schmelzer R; Averill L; Goldberg D
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):107-15. PubMed ID: 7834394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
